A Canadian Perspective on the Challenges for Delivery of Curative-Intent Therapy in Stage III Unresectable Non-Small Cell Lung Cancer

A Canadian Perspective on the Challenges for Delivery of Curative-Intent Therapy in Stage III Unresectable Non-Small Cell Lung Cancer

Stage III non-small cell lung cancer (NSCLC) comprises a highly heterogenous group of patients with regards to patient fitness and tumour size and distribution, resulting in a wide range of treatment goals and therapy options. Curative-intent multimodality treatment should be considered in all patie...

Full description

Bibliographic Details
Main Authors: Anthony Brade, Kevin Jao, Simon Yu, Parneet Cheema, Sarah Doucette, Anna Christofides, Devin Schellenberg
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Current Oncology
Subjects:
stage III non-small cell lung cancer
inoperable
curative-intent
chemoradiation therapy
immunotherapy
care pathway
Online Access:https://www.mdpi.com/1718-7729/28/3/151

Internet

https://www.mdpi.com/1718-7729/28/3/151

Similar Items